Safety of megadose meropenem in the empirical treatment of nosocomial sepsis: a pilot randomized clinical trial.
Sign Up to like & getrecommendations! Published in 2023 at "Future microbiology"
DOI: 10.2217/fmb-2022-0170
Abstract: Objective: To evaluate the safety of megadose meropenem as empirical treatment of nosocomial sepsis. Materials & methods: Critically ill patients diagnosed with sepsis received either high-dose (2 g every 8 h) or megadose (4 g every 8 h) meropenem… read more here.
Keywords: sepsis; empirical treatment; treatment nosocomial; megadose meropenem ... See more keywords